US OKs first drug for dyskinaesia in Parkinson’s patients

US OKs first drug for dyskinaesia in Parkinson's patients

Parkinson’s disease is a debilitating disorder in which brain cells progressively die causing patients to experience tremors, rigidity, extreme slowness of movement, impaired balance, and difficulties in swallowing and speaking.

Adamas is also testing the drug to treat walking impairment in patients with multiple sclerosis

via US OKs first drug for dyskinaesia in Parkinson’s patients

This article is of interest to anybody with Parkinson’s disease or multiple sclerosis as a new drug has been approved by the FDA.

Adamas is the new drug designed to help people with Parkinson’s who suffer from Dyskinesia. Dyskinesia is involuntary movement also known as tremor it’s most common in Parkinson’s disease. But as many as 80% of people with multiple sclerosis according to the National MS Society suffer from tremors as well.

It’s also being tested for people with multiple sclerosis that have impaired walking.

One thing the cost of this drug is estimated at $14,000 per year which is a lot cheaper than my multiple sclerosis medication Copaxone which is over $7,000 a month. I’ll be checking with my doctor to see if I qualify for this drug as my current tremor medications have not completely eliminated my tremors. Although they are working great for my spasticity.

 

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s